Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells
- PMID: 17961621
- DOI: 10.1016/j.taap.2007.09.013
Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells
Abstract
Hepatocyte growth factor (HGF) and its receptor, Met, known to control invasive growth program have recently been shown to play crucial roles in the survival of breast cancer patients. The diet-derived flavonoids have been reported to possess anti-invasion properties; however, knowledge on the pharmacological and molecular mechanisms in suppressing HGF/Met-mediated tumor invasion and metastasis is poorly understood. In our preliminary study, we use HGF as an invasive inducer to investigate the effect of flavonoids including apigenin, naringenin, genistein and kaempferol on HGF-dependent invasive growth of MDA-MB-231 human breast cancer cells. Results show that apigenin presents the most potent anti-migration and anti-invasion properties by Boyden chamber assay. Furthermore, apigenin represses the HGF-induced cell motility and scattering and inhibits the HGF-promoted cell migration and invasion in a dose-dependent manner. The effect of apigenin on HGF-induced signaling activation involving invasive growth was evaluated by immunoblotting analysis, it shows that apigenin blocks the HGF-induced Akt phosphorylation but not Met, ERK, and JNK phosphorylation. In addition to MDA-MB-231 cells, apigenin exhibits inhibitory effect on HGF-induced Akt phosphorylation in hepatoma SK-Hep1 cells and lung carcinoma A549 cells. By indirect immunofluorescence microscopy assay, apigenin inhibits the HGF-induced clustering of beta 4 integrin at actin-rich adhesive site and lamellipodia through PI3K-dependent manner. Treatment of apigenin inhibited HGF-stimulated integrin beta 4 function including cell-matrix adhesion and cell-endothelial cells adhesion in MDA-MB-231 cells. By Akt-siRNA transfection analysis, it confirmed that apigenin inhibited HGF-promoted invasive growth involving blocking PI3K/Akt pathway. Finally, we evaluated the effect of apigenin on HGF-promoted metastasis by lung colonization of tumor cells in nude mice and organ metastasis of tumor cells in chick embryo. By histological and gross examination of mouse lung and real-time PCR analysis of human alu in host tissues, it showed that apigenin, wortmannin, as well as anti-beta 4 antibody all inhibit HGF-promoted metastasis. These data support the inhibitory effect of apigenin on HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and integrin beta 4 function.
Similar articles
-
Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.Chem Biol Interact. 2006 Mar 25;160(2):123-33. doi: 10.1016/j.cbi.2006.01.002. Epub 2006 Feb 3. Chem Biol Interact. 2006. PMID: 16458870
-
Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.Invest Ophthalmol Vis Sci. 2008 Feb;49(2):497-504. doi: 10.1167/iovs.07-0975. Invest Ophthalmol Vis Sci. 2008. PMID: 18234991
-
Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells.Phytomedicine. 2013 Jun 15;20(8-9):743-52. doi: 10.1016/j.phymed.2013.02.004. Epub 2013 Mar 26. Phytomedicine. 2013. PMID: 23537747
-
Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.Proteomics. 2008 Aug;8(16):3360-70. doi: 10.1002/pmic.200800156. Proteomics. 2008. PMID: 18646008 Review.
-
[Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].C R Seances Soc Biol Fil. 1998;192(2):241-51. C R Seances Soc Biol Fil. 1998. PMID: 9841098 Review. French.
Cited by
-
Double-Edged Sword Effect of Diet and Nutrition on Carcinogenic Molecular Pathways in Breast Cancer.Int J Mol Sci. 2024 Oct 15;25(20):11078. doi: 10.3390/ijms252011078. Int J Mol Sci. 2024. PMID: 39456858 Free PMC article. Review.
-
The Hallmarks of Flavonoids in Cancer.Molecules. 2021 Apr 2;26(7):2029. doi: 10.3390/molecules26072029. Molecules. 2021. PMID: 33918290 Free PMC article. Review.
-
Comparative Analysis of Acetylated Flavonoids' Chemopreventive Effects in Different Cancer Cell Lines.Int J Mol Sci. 2024 Jul 13;25(14):7689. doi: 10.3390/ijms25147689. Int J Mol Sci. 2024. PMID: 39062932 Free PMC article.
-
Role of flavonoids in inhibiting triple-negative breast cancer.Front Pharmacol. 2024 Aug 27;15:1411059. doi: 10.3389/fphar.2024.1411059. eCollection 2024. Front Pharmacol. 2024. PMID: 39257397 Free PMC article. Review.
-
Syringic Acid Suppressed Proliferation, Invasion, and Migration via Inhibition of Matrix Metalloproteinases Expression on Glioblastoma Cells by Promoting Apoptosis.Curr Pharm Biotechnol. 2023;24(2):310-316. doi: 10.2174/1389201023666220513100129. Curr Pharm Biotechnol. 2023. PMID: 35570553
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous